[Radionuclide evaluation of renal function in essential hypertensive patients with chronic kidney disease]

Terapevticheskii Arkhiv
|October 24, 2012
PubMed

Insights

Radionuclide imaging using dynamic nephroscintigraphy detects early kidney dysfunction in patients with arterial hypertension and chronic kidney disease. This method offers prognostic value for assessing renal impairment and guiding timely treatment.

Area of Science:

  • Nephrology
  • Nuclear Medicine
  • Cardiology

Background:

  • Arterial hypertension (AH) and chronic kidney disease (CKD) are significant comorbidities.
  • Assessing renal function in AH patients with CKD is crucial for management.
  • Radionuclide imaging offers a non-invasive method for evaluating kidney function.

Purpose of the Study:

  • To evaluate renal function using radionuclide methods in patients with arterial hypertension and chronic kidney disease.
  • To compare renal function in patients with AH and CKD versus CKD patients without AH.
  • To investigate the relationship between glomerular filtration rate (GFR) and renal secretory/excretory function.

Main Methods:

  • Dynamic nephroscintigraphy was performed on 31 patients with AH and CKD.
  • A control group of 8 CKD patients without AH was included.
  • Scintigraphic data were analyzed to assess renal secretory and excretory phases.

Main Results:

  • Statistically significant differences in renal secretory and excretory functions were observed in AH patients with CKD.
  • A deceleration in the secretory phase was noted when GFR was 30-59 ml/min.
  • An acceleration in secretory function, indicated by a 3-fold reduction in peak radio tracer concentration, occurred when GFR was below 30 ml/min (p < 0.001).

Conclusions:

  • Dynamic nephroscintigraphy effectively detects early renal secretory and excretory dysfunctions.
  • The technique provides prognostic value in assessing the severity of renal dysfunction.
  • Early identification of these dysfunctions necessitates timely pharmacological intervention.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...